Acamprosate Safe to Use in Individuals With Liver Disease.

Clinical trial NCT04287920 · COMPLETED

Trial details

NCT number: NCT04287920
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alcohol-related Liver Disease

Start date: 2020-09-21
Primary completion: 2022-01-05
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.